Axcella Health (AXLA) Stock Forecast, Price & News

Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

Is Axcella Health a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Axcella Health stock.
View analyst ratings for Axcella Health or view top-rated stocks.

Are investors shorting Axcella Health?

Axcella Health saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 120,200 shares, a decline of 16.9% from the April 30th total of 144,600 shares. Based on an average trading volume of 74,700 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.5% of the shares of the company are short sold.
View Axcella Health's Short Interest.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Axcella Health.

How were Axcella Health's earnings last quarter?

Axcella Health Inc. (NASDAQ:AXLA) released its quarterly earnings results on Wednesday, March, 30th. The company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by $0.03. During the same quarter in the previous year, the business posted ($0.40) earnings per share.
View Axcella Health's earnings history.

What price target have analysts set for AXLA?

7 analysts have issued twelve-month price objectives for Axcella Health's shares. Their forecasts range from $5.00 to $14.00. On average, they anticipate Axcella Health's stock price to reach $8.00 in the next year. This suggests a possible upside of 308.2% from the stock's current price.
View analysts' price targets for Axcella Health or view top-rated stocks among Wall Street analysts.

Who are Axcella Health's key executives?

Axcella Health's management team includes the following people:

• Mr. William R. Hinshaw Jr., Pres, CEO & Director (Age 53, Pay $830.23k) (LinkedIn Profile)
• Dr. Alison D. Schecter M.D., Pres of R&D, Strategy and Operations (Age 58, Pay $525.53k)
• Mr. Laurent Chardonnet, Consultant (Age 57, Pay $415k)
• Mr. Robert W. Crane, Sr. VP & CFO (Age 63)
• Dr. Paul Fehlner J.D., Ph.D., Sr. VP, Chief Legal Officer & Corp. Sec. (Age 58)
• Ms. Virginia R. Dean, Sr. VP & Chief People Officer (Age 56)
• Dr. Larry Bell, Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP
• Dr. Margaret James Koziel M.D., Sr. VP & Chief Medical Officer (Age 62)
• Mr. Karim Azer Ph.D., VP of Systems Biology & Discovery

What is Bill Hinshaw's approval rating as Axcella Health's CEO?

3 employees have rated Axcella Health CEO Bill Hinshaw on Glassdoor.com. Bill Hinshaw has an approval rating of 100% among Axcella Health's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Axcella Health's key competitors?

Some companies that are related to Axcella Health include Icosavax (ICVX), ADMA Biologics (ADMA), Outlook Therapeutics (OTLK), Monte Rosa Therapeutics (GLUE), MeiraGTx (MGTX), C4 Therapeutics (CCCC), Kodiak Sciences (KOD), Athira Pharma (ATHA), Adagio Therapeutics (ADGI), Opthea (OPT), Talaris Therapeutics (TALS), Compass Therapeutics (CMPX), Tarsus Pharmaceuticals (TARS), Eiger BioPharmaceuticals (EIGR) and Forma Therapeutics (FMTX).
View all of AXLA's competitors.

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Evofem Biosciences (EVFM), ADMA Biologics (ADMA), Coty (COTY), Energy Transfer (ET), Myovant Sciences (MYOV), NVIDIA (NVDA), Pfizer (PFE) and Moderna (MRNA).

When did Axcella Health IPO?

(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

Who are Axcella Health's major shareholders?

Axcella Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Flagship Pioneering Inc. (35.88%), HarbourVest Partners LLC (8.33%), Vanguard Group Inc. (1.44%), Edgewood Management LLC (0.19%), Pinnacle Private Wealth LLC (0.06%) and Cutter & CO Brokerage Inc. (0.04%). Company insiders that own Axcella Health stock include David R Epstein, Des Produits Nestle S Societe, Manu Chakravarthy, Paul Fehlner, Robert Crane and William Hinshaw.
View institutional ownership trends for Axcella Health.

Which institutional investors are selling Axcella Health stock?

AXLA stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., and Cutter & CO Brokerage Inc..
View insider buying and selling activity for Axcella Health or view top insider-selling stocks.

Which institutional investors are buying Axcella Health stock?

AXLA stock was bought by a variety of institutional investors in the last quarter, including Flagship Pioneering Inc., HarbourVest Partners LLC, Edgewood Management LLC, Pinnacle Private Wealth LLC, and Simplex Trading LLC. Company insiders that have bought Axcella Health stock in the last two years include David R Epstein, Des Produits Nestle S Societe, Paul Fehlner, Robert Crane, and William Hinshaw.
View insider buying and selling activity for Axcella Health or or view top insider-buying stocks.

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $1.96.

How much money does Axcella Health make?

Axcella Health has a market capitalization of $103.05 million. The company earns $-64.63 million in net income (profit) each year or ($1.75) on an earnings per share basis.

How many employees does Axcella Health have?

Axcella Health employs 59 workers across the globe.

What is Axcella Health's official website?

The official website for Axcella Health is www.axcellahealth.com.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at (857) 320-2200, via email at [email protected], or via fax at 617-441-6243.